[1]孙鹏飞,王华东.前列舒通联合盐酸坦索罗辛治疗慢性前列腺炎的疗效及对血清PSA、NGF、TGF-β的影响[J].医学信息,2023,36(15):144-147.[doi:10.3969/j.issn.1006-1959.2023.15.030]
　SUN Peng-fei,WANG Hua-dong.Efficacy of Qianlie Shutong Combined with Tamsulosin Hydrochloride in the Treatment of Chronic Prostatitis and its Effect on Serum PSA, NGF and TGF-β[J].Journal of Medical Information,2023,36(15):144-147.[doi:10.3969/j.issn.1006-1959.2023.15.030]
点击复制

前列舒通联合盐酸坦索罗辛治疗慢性前列腺炎的疗效及对血清PSA、NGF、TGF-β的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年15期
页码:
144-147
栏目:
论著
出版日期:
2023-08-01

文章信息/Info

Title:
Efficacy of Qianlie Shutong Combined with Tamsulosin Hydrochloride in the Treatment of Chronic Prostatitis and its Effect on Serum PSA, NGF and TGF-β
文章编号:
1006-1959（2023）15-0144-04
作者:
孙鹏飞; 王华东
（天津市宝坻区人民医院泌尿外科，天津 301800）
Author(s):
SUN Peng-fei; WANG Hua-dong
(Department of Urology Surgery,Baodi District People’s Hospital,Tianjin 301800,China）
关键词:
慢性前列腺炎; 前列舒通; 盐酸坦索罗辛; 前列腺特异性抗原; 神经生长因子; 转化生长因子
Keywords:
Chronic prostatitis; Qianlie Shutong; Tamsulosin hydrochloride; Prostate specific antigen; Nerve growth factor; Transforming growth factor
分类号:
R277.5
DOI:
10.3969/j.issn.1006-1959.2023.15.030
文献标志码:
A
摘要:
目的 研究前列舒通联合盐酸坦索罗辛治疗慢性前列腺炎（CP）的疗效及对患者血清前列腺特异性抗原（PSA）、神经生长因子（NGF）、转化生长因子（TGF-β）的影响。方法 选取2021年3月-2022年3月天津市宝坻区人民医院泌尿外科收治的82例CP患者，采用随机数字表法分为对照组（41例）与观察组（41例）。对照组给予盐酸坦索罗辛治疗，观察组采用前列舒通联合盐酸坦索罗辛治疗。比较两组临床疗效、慢性前列腺炎症状评分（NIH-CPSI）、血清PSA、NGF、TGF-β水平、前列腺液炎性因子[白介素-8（IL-8）、肿瘤坏死因子α（TNF-α）]水平。结果 观察组总有效率高于对照组（P＜0.05）；观察组治疗后NIH-CPSI评分3个方面（疼痛或不适症状、排尿症状、症状对生活质量的影响）均低于对照组（P＜0.05）；观察组治疗后血清PSA、NGF、TGF-β水平低于对照组，前列腺液IL-8、TNF-α水平低于对照组（P＜0.05）。结论 前列舒通联合盐酸坦索罗辛治疗CP疗效肯定，可有效改善患者症状，下调机体PSA、NGF、TGF-β水平，减轻炎性反应，值得临床应用。
Abstract:
Objective To study the efficacy of Qianlie Shutong combined with tamsulosin hydrochloride in the treatment of chronic prostatitis (CP) and its effect on serum prostate specific antigen (PSA), nerve growth factor (NGF) and transforming growth factor (TGF-β).Methods A total of 82 patients with CP admitted to the Department of Urology, Tianjin Baodi District People’s Hospital from March 2021 to March 2022 were selected and divided into control group (41 patients) and observation group (41 patients) by random number table method. The control group was treated with tamsulosin hydrochloride, and the observation group was treated with Qianlie Shutong combined with tamsulosin hydrochloride. The clinical efficacy, chronic prostatitis symptom score (NIH-CPSI), serum PSA, NGF, TGF-β levels, prostatic fluid inflammatory factors [interleukin-8 (IL-8), tumor necrosis factor-α (TNF-α)] levels were compared between the two groups.Results The total effective rate of the observation group was higher than that of the control group (P<0.05). After treatment, the NIH-CPSI scores in three aspects (pain or discomfort symptoms, urination symptoms, and effects of symptoms on quality of life)of the observation group were lower than those of the control group (P<0.05). After treatment, the levels of serum PSA, NGF and TGF-β in the observation group were lower than those in the control group, and the levels of IL-8 and TNF-α in prostatic fluid were lower than those in the control group (P<0.05).Conclusion Qianlie Shutong combined with tamsulosin hydrochloride is effective in the treatment of CP, which can effectively improve the symptoms of patients, down-regulate the levels of PSA, NGF and TGF-β, and reduce the inflammatory response. It is worthy of clinical application.

参考文献/References:

[1]Zhu H,Weng BW,Zhao HJ,et al.Clinical observation of retention enema with Compound Cortex Phellodendri Ye Paints on type IIIA chronic prostatitis[J].Chinese Journal of New Drugs,2017,26(23):2826-2829.[2]张志杰.前列舒通胶囊联合盐酸坦索罗辛胶囊治疗经尿道前列腺切除术后患者的效果及对炎性因子水平的影响[J].中国中西医结合外科杂志,2021,27(3):447-450.[3]李月兵,邢家龙,宗朝晖,等.坦索罗辛与左氧氟沙星对慢性前列腺炎的临床效果[J].中国医药导报,2021,18(15):84-87.[4]唐硕,李云祥.观察盐酸坦索罗辛与抗感染药物结合治疗慢性前列腺炎的疗效[J].中国性科学,2018,27(8):25-28.[5]Tian R,Zhao L,Zhao F,et al.143 Effectiveness of Dapoxetine combined with Tamsulosin in the treatment of premature ejaculation secondary to category ⅢB chronic prostatitis: a multicenter clinical study[J].Journal of Sexual Medicine,2018,15(7):S189-S190.[6]刘畅,姜婷婷,张聪,等.前列舒通胶囊治疗慢性前列腺炎的有效性、安全性、经济性系统评价[J].中华男科学杂志,2019,25(5):444-450.[7]侯惠民,刘明,白文俊,等.前列舒通治疗慢性非细菌性前列腺炎的多中心开放单臂自身对照临床研究[J].现代泌尿外科杂志,2020,25(12):1103-1106,1110.[8]高文喜,郭凡,韩瑞发,等.中西医结合诊疗前列腺炎专家共识[J].中国中西医结合外科杂志,2022,28(4):451-455.[9]卞军,周其赵,杨建昆,等.盐酸坦索罗辛胶囊联合盐酸达泊西汀片治疗ⅢB型慢性前列腺炎继发早泄的多中心临床分析[J].临床泌尿外科杂志,2018,33(10):818-820,824.[10]Alexander RB,Propert KJ,Schaeffer AJ,et al.Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial[J].Annals of Internal Medicine,2019,141(8):581-589.[11]王治国.坦索罗辛联合泼尼松龙治疗Ⅲ型前列腺炎的疗效及对B7-H3、IFN-γ、IL-10表达的影响[J].川北医学院学报,2017,32(2):230-232,253.[12]申军,常青,吴栖岸,等.复元活血汤联合坦索罗辛治疗气滞血瘀型慢性前列腺炎疗效及对IL-8、TNF-α影响的研究[J].中国地方病防治杂志,2018,33(1):57-58.[13]曾定胜,何跃,肖艳红,等.前列舒通胶囊联合盐酸坦索罗辛胶囊对慢性非细菌性前列腺炎炎症因子水平的影响及其临床疗效[J].国际泌尿系统杂志,2017,37(6):865-869.[14]李富东,孔飞燕,张斌,等.前列舒通胶囊联合坦索罗辛治疗慢性前列腺炎伴早泄的临床疗效观察[J].西北国防医学杂志,2019,40(1):20-24.[15]李征.前列舒通胶囊联合坦索罗辛治疗IIIB型前列腺炎的疗效观察[J].现代药物与临床,2017,32(2):293-295.[16]南玉奎,胡晓刚,张志强,等.前列舒通胶囊联合α-受体阻滞剂治疗Ⅲ型前列腺炎疗效观察[J].国际泌尿系统杂志,2019,39(1):37-39.[17]贺元才,王荣江.盐酸坦索罗辛对慢性前列腺炎患者血清炎症因子的影响[J].中国性科学,2017,26(2):5-7.[18]郭江,陈本华.隔姜灸联合盐酸坦索罗辛胶囊治疗慢性前列腺炎/慢性骨盆疼痛综合征(CP/CPPS)临床疗效及机制研究[J].四川中医,2018,36(1):178-181.[19]操作亮,章传华,黄遂斌,等.前列舒通联合盐酸坦索罗辛治疗慢性前列腺炎疗效评价及对血清PSA、NGF、TGF-β的影响[J].中华中医药学刊,2019,37(8):1981-1985.[20]景中民,朱海松,徐海亮,等.前列舒通胶囊联合盐酸坦索罗辛胶囊治疗湿热瘀阻型前列腺炎临床研究[J].陕西中医,2019,40(3):294-296.

相似文献/References:

[1]冯友亮.舍曲林联合坦索罗辛治疗慢性前列腺炎顽固性尿道疼痛的近期疗效[J].医学信息,2019,32(24):81.[doi:10.3969/j.issn.1006-1959.2019.24.026]
　FENG You-liang.Short-term Efficacy of Sertraline Combined with Tamsulosin in the Treatment of Refractory Urethral Pain in Chronic Prostatitis[J].Journal of Medical Information,2019,32(15):81.[doi:10.3969/j.issn.1006-1959.2019.24.026]
[2]李风雷,韩紫阳,邱玲艳,等.萆菟汤治疗慢性前列腺炎的网络药理学研究[J].医学信息,2023,36(08):1.[doi:10.3969/j.issn.1006-1959.2023.08.001]
　LI Feng-lei,HAN Zi-yang,QIU Ling-yan,et al.Study on Network Pharmacology of Bitu Decoction in the Treatment of Chronic Prostatitis[J].Journal of Medical Information,2023,36(15):1.[doi:10.3969/j.issn.1006-1959.2023.08.001]

更新日期/Last Update: 1900-01-01